Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer

SIMPLE SUMMARY: Despite the clinical benefit of new anticancer therapies, such as immune checkpoint inhibitors, lung cancer remains the most frequent cause of cancer-related death worldwide, thus supporting the need to develop novel anticancer treatments. Endothelial cells of the tumor-associated va...

Descripción completa

Detalles Bibliográficos
Autores principales: Valério-Fernandes, Ângela, Fonseca, Nuno A., Gonçalves, Nélio, Cruz, Ana F., Pereira, Marta I., Gregório, Ana C., Moura, Vera, Ladeirinha, Ana F., Alarcão, Ana, Gonçalves, Joana, Abrunhosa, Antero, Melo, Joana B., Carvalho, Lina, Simões, Sérgio, Moreira, João N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101044/
https://www.ncbi.nlm.nih.gov/pubmed/35565346
http://dx.doi.org/10.3390/cancers14092217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101044/
https://www.ncbi.nlm.nih.gov/pubmed/35565346
http://dx.doi.org/10.3390/cancers14092217

Ejemplares similares